RxDoctor Payments DataLook up a doctor →

William Bauer, MD

Internal Medicine · Bremerton, WANPI 1902887276

Payments from drug & device makers

$10,894in general payments, 2019–2025

Across 361 payments — averaging $30.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • AstraZeneca$973
  • Lilly USA, LLC$917
  • Novo Nordisk$905
  • Otsuka America Pharmaceutical, Inc.$737
  • AbbVie$466
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen42$1,060
AstraZeneca26$973
Lilly USA, LLC35$917
Novo Nordisk36$905
Otsuka America Pharmaceutical, Inc.15$737
AbbVie(2 entities)19$466
Sunovion Pharmaceuticals Inc.11$329
Teva Pharmaceuticals USA, Inc.6$305
Boehringer Ingelheim10$281
Bayer7$265
Abbott2$227
Neurocrine Biosciences, Inc.4$220
Merck9$210
Neurelis, Inc.4$190
Esperion Therapeutics, Inc.4$188
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$173
Astellas Pharma US Inc7$173
Amarin Pharma, Inc.6$172
Pfizer9$165
Sanofi-aventis U.S. LLC5$164
Corcept Therapeutics4$159
Johnson & Johnson8$154
Idorsia Pharmaceuticals US Inc7$151
Bristol Myers Squibb8$148
Axsome Therapeutics, Inc.2$147
Biohaven Pharmaceuticals, Inc.2$145
Genentech USA, Inc.1$121
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$119
Novartis6$118
Madrigal Pharmaceuticals1$116
Organogenesis Inc.1$108
EMD Serono, Inc.2$106
Sumitomo Pharma America, Inc.4$97
Alkermes, Inc.1$91
Takeda Pharmaceuticals U.S.A., Inc.3$74
Lifescan, Inc.3$72
Phathom Pharmaceuticals, Inc.2$69
E.r. Squibb & Sons, L.L.C.3$67
Mylan Specialty L.p.3$65
GSK3$54
Eisai Inc.2$50
Biogen2$48
Exact Sciences2$45
Viatris Specialty LLC2$43
Shield Therapeutics Inc2$42
Radius Health, Inc.2$38
Edwards Lifesciences1$32
Corium, LLC1$29
Medicomp Inc1$27
Azurity Pharmaceuticals, Inc.1$25
Ascensia Diabetes Care US Inc.1$24
Medtronic1$22
Nestle Healthcare Nutrition Inc.1$22
Xeris Pharmaceuticals, Inc.1$22
Linus Health, Inc.1$21
Lexicon Pharmaceuticals, Inc.1$21
Biohaven Pharmaceutical Holding Company Ltd.1$19
Lundbeck LLC1$19
Acadia Pharmaceuticals Inc1$16
Acorda Therapeutics, Inc1$16

How this compares

$10,894 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.

See all internal medicine providers in Washington →

Medicare billing

Part B allowed, 2024
$173,333
Medicare patients
300
Services billed
2,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Bremerton

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →